{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:36:44Z","timestamp":1792255004181,"version":"4.4.0"},"reference-count":133,"publisher":"The Journal of Rheumatology","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,11,7]]},"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:p>\n                    Interstitial lung disease (ILD), characterized by pulmonary fibrosis and\/or inflammation, is a common and severe extraarticular manifestation of rheumatoid arthritis (RA). RA-ILD is associated with reduced quality of life and increased mortality. Among people with RA, up to 15% develop clinically significant ILD, and even more have subclinical disease (radiologic abnormalities without symptoms). The most common RA-ILD patterns on chest high-resolution computed tomography (CT) imaging are usual interstitial pneumonia (UIP; the prototypic fibrotic subtype) and nonspecific interstitial pneumonia (the subtype characterized by inflammation). In this narrative review, we detail the current state of evidence for RA-ILD screening and the next steps needed to justify screening in some subgroups. Some current or former smokers with RA may currently qualify for lung cancer screening with low-dose CT imaging, which may also detect ILD. The 2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for screening and monitoring of ILD conditionally recommended screening people with RA with an ILD risk factor (ie, male sex, older age, smoking, RA-related autoantibody elevation, obesity, and high RA disease activity). Several genetic and blood biomarkers are associated with RA-ILD. The\n                    <jats:italic>MUC5B<\/jats:italic>\n                    promoter variant is the strongest genetic risk factor for RA-ILD, specifically the UIP subtype. Proposed screening strategies show promise for accurately detecting RA-ILD; however, there has been less research on other consequences of screening for RA-ILD, including cost, anxiety, radiation exposure, incidental findings, and downstream clinical follow-up. Clinical trials are needed to identify an intervention that alters the natural history for those found to have subclinical RA-ILD on screening.\n                  <\/jats:p>","DOI":"10.3899\/jrheum.2025-0797","type":"journal-article","created":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T14:05:39Z","timestamp":1764597939000},"page":"362-375","source":"Crossref","is-referenced-by-count":7,"title":["Screening for Rheumatoid Arthritis\u2013Associated Interstitial Lung Disease: Current Evidence and Next Steps Needed for Routine Clinical Use"],"prefix":"10.3899","volume":"53","author":[{"given":"Lauren A.","family":"O\u2019Keeffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liya Sisay","family":"Getachew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suchita P.","family":"Nety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alene A.","family":"Saavedra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie A.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin T.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory C.","family":"McDermott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5556-4618","authenticated-orcid":false,"given":"Jeffrey A.","family":"Sparks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,12,1]]},"reference":[{"key":"2026040105300592000_53.4.362.1","first-page":"16","article-title":"Methotrexate in rheumatoid arthritis: a quarter century of development","volume":"124","author":"Weinblatt","year":"2013","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"2026040105300592000_53.4.362.2","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1002\/acr.25053","article-title":"A narrowing mortality gap: temporal trends of cause-specific mortality in a national matched cohort study in US veterans with rheumatoid arthritis","volume":"75","author":"Johnson","year":"2023","journal-title":"Arthritis Care Res"},{"key":"2026040105300592000_53.4.362.3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/acr.25231","article-title":"Decline in incidence of extra-articular manifestations of rheumatoid arthritis: a population-based cohort study","volume":"76","author":"Kimbrough","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026040105300592000_53.4.362.4","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211138"},{"key":"2026040105300592000_53.4.362.5","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.171315"},{"key":"2026040105300592000_53.4.362.6","doi-asserted-by":"crossref","first-page":"152187","DOI":"10.1016\/j.semarthrit.2023.152187","article-title":"Survival of adults with rheumatoid arthritis associated interstitial lung disease\u2014a systematic review and meta-analysis","volume":"60","author":"Farquhar","year":"2023","journal-title":"Semin Arthritis Rheum"},{"key":"2026040105300592000_53.4.362.7","doi-asserted-by":"crossref","first-page":"SI286","DOI":"10.1093\/rheumatology\/kead277","article-title":"Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers","volume":"62","author":"McDermott","year":"2023","journal-title":"Rheumatology"},{"key":"2026040105300592000_53.4.362.8","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000787"},{"key":"2026040105300592000_53.4.362.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa836"},{"key":"2026040105300592000_53.4.362.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2020.08.015"},{"key":"2026040105300592000_53.4.362.11","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22752"},{"key":"2026040105300592000_53.4.362.12","doi-asserted-by":"publisher","DOI":"10.1007\/s40674-020-00160-z"},{"key":"2026040105300592000_53.4.362.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2023.152312"},{"key":"2026040105300592000_53.4.362.14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S2213-2600(22)00260-0","article-title":"Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study","volume":"11","author":"Solomon","year":"2023","journal-title":"Lancet Respir Med"},{"key":"2026040105300592000_53.4.362.15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2026040105300592000_53.4.362.16","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa2503643","article-title":"Nerandomilast in patients with progressive pulmonary fibrosis","volume":"392","author":"Maher","year":"2025","journal-title":"N Engl J Med"},{"key":"2026040105300592000_53.4.362.17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s40674-024-00217-3","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: an appraisal of the 2023 ACR\/CHEST guideline","volume":"10","author":"Saavedra","year":"2024","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"2026040105300592000_53.4.362.18","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the treatment of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.19","first-page":"S3","article-title":"Screening, diagnosis, and monitoring of interstitial lung disease in autoimmune rheumatic diseases: a narrative review","volume":"31","author":"Good","year":"2024","journal-title":"Rev Colomb Reumatol"},{"key":"2026040105300592000_53.4.362.20","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.171154"},{"key":"2026040105300592000_53.4.362.21","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0011-2021"},{"key":"2026040105300592000_53.4.362.22","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201004-0622OC"},{"key":"2026040105300592000_53.4.362.23","doi-asserted-by":"publisher","DOI":"10.1002\/art.27405"},{"key":"2026040105300592000_53.4.362.24","doi-asserted-by":"publisher","DOI":"10.1183\/09059180.00008014"},{"key":"2026040105300592000_53.4.362.25","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.12.004"},{"key":"2026040105300592000_53.4.362.26","doi-asserted-by":"crossref","first-page":"e221172","DOI":"10.1148\/radiol.221172","article-title":"Prevalence and long-term outcomes of CT interstitial lung abnormalities in a health screening cohort","volume":"306","author":"Lee","year":"2023","journal-title":"Radiology"},{"key":"2026040105300592000_53.4.362.27","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1093\/rheumatology\/keab891","article-title":"Screening for preclinical parenchymal lung disease in rheumatoid arthritis","volume":"61","author":"Esposito","year":"2022","journal-title":"Rheumatology"},{"key":"2026040105300592000_53.4.362.28","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-015-3025-8"},{"key":"2026040105300592000_53.4.362.29","doi-asserted-by":"crossref","first-page":"406927","DOI":"10.1155\/2013\/406927","article-title":"Asymptomatic preclinical rheumatoid arthritis-associated interstitial lung disease","volume":"2013","author":"Chen","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2026040105300592000_53.4.362.30","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0210-2022"},{"key":"2026040105300592000_53.4.362.31","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq035"},{"key":"2026040105300592000_53.4.362.32","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-2600(20)30168-5","article-title":"Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner Society","volume":"8","author":"Hatabu","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026040105300592000_53.4.362.33","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202505-1054ST"},{"key":"2026040105300592000_53.4.362.34","doi-asserted-by":"crossref","first-page":"e116","DOI":"10.1016\/S2665-9913(23)00033-4","article-title":"Preclinical or subclinical rheumatoid arthritis-associated interstitial lung disease: misleading terms with potentially deleterious consequences","volume":"5","author":"Volkmann","year":"2023","journal-title":"Lancet Rheumatol"},{"key":"2026040105300592000_53.4.362.35","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.156.2.9609016"},{"key":"2026040105300592000_53.4.362.36","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.42162","article-title":"A risk score to detect subclinical rheumatoid arthritis-associated interstitial lung disease","volume":"74","author":"Juge","year":"2022","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.37","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202109-2087LE"},{"key":"2026040105300592000_53.4.362.38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.127.6.2019"},{"key":"2026040105300592000_53.4.362.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.04.004"},{"key":"2026040105300592000_53.4.362.40","doi-asserted-by":"publisher","DOI":"10.1186\/ar3037"},{"key":"2026040105300592000_53.4.362.41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.3390\/jcm9041082","article-title":"Treatment of rheumatoid arthritis-associated interstitial lung disease: lights and shadows","volume":"9","author":"Cassone","year":"2020","journal-title":"J Clin Med"},{"key":"2026040105300592000_53.4.362.42","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.semarthrit.2019.04.005","article-title":"Impact of the pattern of interstitial lung disease on mortality in rheumatoid arthritis: a systematic literature review and meta-analysis","volume":"49","author":"Singh","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2026040105300592000_53.4.362.43","doi-asserted-by":"crossref","first-page":"22037","DOI":"10.1038\/s41598-022-26510-6","article-title":"Sensitivity of transbronchial lung cryobiopsy in the diagnosis of different interstitial lung diseases","volume":"12","author":"Zaizen","year":"2022","journal-title":"Sci Rep"},{"key":"2026040105300592000_53.4.362.44","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150166"},{"key":"2026040105300592000_53.4.362.45","doi-asserted-by":"crossref","first-page":"9184","DOI":"10.1038\/s41598-021-88734-2","article-title":"Diagnostic delay of associated interstitial lung disease increases mortality in rheumatoid arthritis","volume":"11","author":"Cano-Jim\u00e9nez","year":"2021","journal-title":"Sci Rep"},{"key":"2026040105300592000_53.4.362.46","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/art.39971","article-title":"Progressive decline of lung function in rheumatoid arthritis-associated interstitial lung disease","volume":"69","author":"Zamora-Legoff","year":"2017","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.47","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1007\/s10067-024-07028-w","article-title":"Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease","volume":"43","author":"Venkat","year":"2024","journal-title":"Clin Rheumatol"},{"key":"2026040105300592000_53.4.362.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2014.01.858"},{"key":"2026040105300592000_53.4.362.49","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12890-023-02532-2","article-title":"Incidence, risk factors, and prognosis of acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis","volume":"23","author":"Xie","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2026040105300592000_53.4.362.50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2106\/00004623-198870030-00004","article-title":"The uncemented porous-coated anatomic total hip prosthesis. Two-year results of a prospective consecutive series","volume":"70","author":"Callaghan","year":"1988","journal-title":"J Bone Joint Surg Am"},{"key":"2026040105300592000_53.4.362.51","doi-asserted-by":"crossref","first-page":"3806","DOI":"10.3390\/jcm10173806","article-title":"Decision-making strategy for the treatment of rheumatoid arthritis-associated interstitial lung disease (RA-ILD)","volume":"10","author":"Yamakawa","year":"2021","journal-title":"J Clin Med"},{"key":"2026040105300592000_53.4.362.52","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa577"},{"key":"2026040105300592000_53.4.362.53","doi-asserted-by":"crossref","first-page":"151626","DOI":"10.1155\/2015\/151626","article-title":"Anti-cyclic citrullinated peptide antibodies and severity of interstitial lung disease in women with rheumatoid arthritis","volume":"2015","author":"Rocha-Mu\u00f1oz","year":"2015","journal-title":"J Immunol Res"},{"key":"2026040105300592000_53.4.362.54","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.40904","article-title":"Rheumatoid arthritis disease activity predicting incident clinically apparent rheumatoid arthritis-associated interstitial lung disease: a prospective cohort study","volume":"71","author":"Sparks","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s13075-024-03449-9","article-title":"Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis\u2014a nested case-control study within the German biologics register Rabbit","volume":"26","author":"Ramien","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2026040105300592000_53.4.362.56","doi-asserted-by":"crossref","first-page":"152561","DOI":"10.1016\/j.semarthrit.2024.152561","article-title":"Disease-modifying antirheumatic drugs and risk of incident interstitial lung disease among patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"69","author":"Zhang","year":"2024","journal-title":"Semin Arthritis Rheum"},{"key":"2026040105300592000_53.4.362.57","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1007\/s10067-022-06245-5","article-title":"Can we finally exonerate methotrexate as a factor in causing or exacerbating fibrotic interstitial lung disease in patients with rheumatoid arthritis?","volume":"41","author":"Mehta","year":"2022","journal-title":"Clin Rheumatol"},{"key":"2026040105300592000_53.4.362.58","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1002\/art.41452","article-title":"Pulmonary adverse events in patients receiving low-dose methotrexate in the randomized, double-blind, placebo-controlled cardiovascular inflammation reduction trial","volume":"72","author":"Sparks","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.59","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00337-2020"},{"key":"2026040105300592000_53.4.362.60","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s10067-016-3357-z","article-title":"Risk of serious infection in patients with rheumatoid arthritis-associated interstitial lung disease","volume":"35","author":"Zamora-Legoff","year":"2016","journal-title":"Clin Rheumatol"},{"key":"2026040105300592000_53.4.362.61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s40266-024-01175-0","article-title":"Patient-centric approach for the treatment of rheumatoid arthritis-associated interstitial lung disease in older people","volume":"42","author":"Mueller","year":"2025","journal-title":"Drugs Aging"},{"key":"2026040105300592000_53.4.362.62","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1002\/art.42961","article-title":"The risk of lung cancer in rheumatoid arthritis and rheumatoid arthritis-associated interstitial lung disease","volume":"76","author":"Brooks","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.04.061"},{"key":"2026040105300592000_53.4.362.64","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00393-023-01464-w","article-title":"Screening for rheumatoid arthritis-associated interstitial lung disease-a Delphi-based consensus statement","volume":"83","author":"Hackner","year":"2024","journal-title":"Z Rheumatol"},{"key":"2026040105300592000_53.4.362.65","doi-asserted-by":"crossref","first-page":"152578","DOI":"10.1016\/j.semarthrit.2024.152578","article-title":"Rheumatoid arthritis-associated interstitial lung disease: advancing the identification and management","volume":"70S","author":"England","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026040105300592000_53.4.362.66","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.reuma.2021.07.008","article-title":"Screening of interstitial lung disease in patients with rheumatoid arthritis: a systematic review","volume":"18","author":"Garrote-Corral","year":"2022","journal-title":"Reumatol Clin"},{"key":"2026040105300592000_53.4.362.67","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01922-2"},{"key":"2026040105300592000_53.4.362.68","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/1759-7714.13406","article-title":"Assessment of anxiety and depression in patients with incidental pulmonary nodules and analysis of its related impact factors","volume":"11","author":"Li","year":"2020","journal-title":"Thorac Cancer"},{"key":"2026040105300592000_53.4.362.69","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1164\/rccm.202501-0011ST","article-title":"Lung cancer screening and incidental findings: a research agenda: an official American Thoracic Society research statement","volume":"211","author":"Henderson","year":"2025","journal-title":"Am J Respir Crit Care Med"},{"key":"2026040105300592000_53.4.362.70","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/acr.25346","article-title":"Assessing patient values and preferences to inform the 2023 American College of Rheumatology\/American College of Chest Physicians interstitial lung disease guidelines","volume":"76","author":"Mirza","year":"2024","journal-title":"Arthritis Care Res"},{"key":"2026040105300592000_53.4.362.71","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-019-0980-7"},{"key":"2026040105300592000_53.4.362.72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"2026040105300592000_53.4.362.73","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1002\/art.42860","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) guideline for the screening and monitoring of interstitial lung disease in people with systemic autoimmune rheumatic diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.74","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2026040105300592000_53.4.362.75","first-page":"1951","article-title":"High-resolution computed tomography of the chest for the screening, re-screening and follow-up of systemic sclerosis-associated interstitial lung disease: a EUSTAR-SCTC survey","volume":"40","author":"Bruni","year":"2022","journal-title":"Clin Exp Rheumatol"},{"key":"2026040105300592000_53.4.362.76","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/S2213-2600(19)30480-1","article-title":"Systemic sclerosis-associated interstitial lung disease","volume":"8","author":"Perelas","year":"2020","journal-title":"Lancet Respir Med"},{"key":"2026040105300592000_53.4.362.77","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02026-2019"},{"key":"2026040105300592000_53.4.362.78","doi-asserted-by":"crossref","first-page":"152729","DOI":"10.1016\/j.semarthrit.2025.152729","article-title":"Development of a prediction model for progression of rheumatoid arthritis-associated interstitial lung disease using serologic and clinical factors: the prospective KORAIL cohort","volume":"73","author":"Chang","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"2026040105300592000_53.4.362.79","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.2024-0713"},{"key":"2026040105300592000_53.4.362.80","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2026040105300592000_53.4.362.81","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0073-2018"},{"key":"2026040105300592000_53.4.362.82","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0206-2021"},{"key":"2026040105300592000_53.4.362.83","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2345"},{"key":"2026040105300592000_53.4.362.84","doi-asserted-by":"publisher","DOI":"10.7326\/M13-2771."},{"key":"2026040105300592000_53.4.362.85","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0377"},{"key":"2026040105300592000_53.4.362.86","doi-asserted-by":"publisher","DOI":"10.1186\/ar4498"},{"key":"2026040105300592000_53.4.362.87","doi-asserted-by":"publisher","DOI":"10.1002\/acr.23837"},{"key":"2026040105300592000_53.4.362.88","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-016-0563-2"},{"key":"2026040105300592000_53.4.362.89","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/art.39630","article-title":"Associations of smoking and age with inflammatory joint signs among unaffected first-degree relatives of rheumatoid arthritis patients: results from studies of the etiology of rheumatoid arthritis","volume":"68","author":"Sparks","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.90","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2014.07.005"},{"key":"2026040105300592000_53.4.362.91","doi-asserted-by":"crossref","unstructured":"McDermott GC , Hammer M , Wang X , Detection of lung abnormalities in smokers with rheumatoid arthritis screened for lung cancer with low-dose chest computed tomography imaging in routine clinical care: results from a large multi-hospital system. Arthritis Care Res 2025 Oct 27 (Epub ahead of print).","DOI":"10.1002\/acr.25680"},{"key":"2026040105300592000_53.4.362.92","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1513\/AnnalsATS.202006-590OC","article-title":"Autoantibody seropositivity and risk for interstitial lung disease in a prospective male-predominant rheumatoid arthritis cohort of U.S. Veterans","volume":"18","author":"Natalini","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026040105300592000_53.4.362.93","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2012.07.006"},{"key":"2026040105300592000_53.4.362.94","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-203160"},{"key":"2026040105300592000_53.4.362.95","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2007.59"},{"key":"2026040105300592000_53.4.362.96","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780391014"},{"key":"2026040105300592000_53.4.362.97","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12890-019-0875-x","article-title":"Diagnostic accuracy of a Velcro sound detector (VECTOR) for interstitial lung disease in rheumatoid arthritis patients: the InSPIRAtE validation study (interstitial pneumonia in rheumatoid arthritis with an electronic device)","volume":"19","author":"Manfredi","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2026040105300592000_53.4.362.98","doi-asserted-by":"publisher","DOI":"10.1002\/art.20265"},{"key":"2026040105300592000_53.4.362.99","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1513\/AnnalsATS.202104-466OC","article-title":"Impact of lung biopsy information on treatment strategy of patients with interstitial lung diseases","volume":"19","author":"Tomassetti","year":"2022","journal-title":"Ann Am Thorac Soc"},{"key":"2026040105300592000_53.4.362.100","doi-asserted-by":"publisher","DOI":"10.1016\/j.reumae.2021.12.003"},{"key":"2026040105300592000_53.4.362.101","unstructured":"Antoniou KM , Distler O , Gheorghiu AM , ERS\/EULAR clinical practice guidelines for connective tissue diseases associated interstitial lung disease. Ann Rheum Dis 2025: S0003-4967(25)04320-1."},{"key":"2026040105300592000_53.4.362.102","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10067-020-05320-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: an overview of epidemiology, pathogenesis and management","volume":"40","author":"Dai","year":"2021","journal-title":"Clin Rheumatol"},{"key":"2026040105300592000_53.4.362.103","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/acr2.11535","article-title":"Peripheral blood biomarkers for rheumatoid arthritis-associated interstitial lung disease: a systematic review","volume":"5","author":"Van Kalsbeek","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2026040105300592000_53.4.362.104","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801562"},{"key":"2026040105300592000_53.4.362.105","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217256"},{"key":"2026040105300592000_53.4.362.106","doi-asserted-by":"crossref","first-page":"rkae059","DOI":"10.1093\/rap\/rkae059","article-title":"RPA3-UMAD1 rs12702634 and rheumatoid arthritis-associated interstitial lung disease in European ancestry","volume":"8","author":"Juge","year":"2024","journal-title":"Rheumatol Adv Pract"},{"key":"2026040105300592000_53.4.362.107","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/rheumatology\/keae001","article-title":"Development and internal validation of a clinical and genetic risk score for rheumatoid arthritis-associated interstitial lung disease","volume":"64","author":"Wheeler","year":"2025","journal-title":"Rheumatology"},{"key":"2026040105300592000_53.4.362.108","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02314-2016"},{"key":"2026040105300592000_53.4.362.109","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/art.38904","article-title":"Biomarkers of rheumatoid arthritis-associated interstitial lung disease","volume":"67","author":"Chen","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.110","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201411-1950OC"},{"key":"2026040105300592000_53.4.362.111","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/1756-185X.14084","article-title":"Identification of serum interleukin-13 and interleukin-13 receptor subunit expressions: rheumatoid arthritis-associated interstitial lung disease","volume":"24","author":"Hussein","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"2026040105300592000_53.4.362.112","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/art.42812","article-title":"Plasma matrix metalloproteinase concentrations and risk of interstitial lung disease in a prospective rheumatoid arthritis cohort","volume":"76","author":"Luedders","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0229997"},{"key":"2026040105300592000_53.4.362.114","doi-asserted-by":"publisher","DOI":"10.1016\/s2665-9913(22)00380-0"},{"key":"2026040105300592000_53.4.362.115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/acr.25432","article-title":"Impact of sex, serostatus, and smoking on risk for rheumatoid arthritis-associated interstitial lung disease subtypes","volume":"77","author":"McDermott","year":"2025","journal-title":"Arthritis Care Res"},{"key":"2026040105300592000_53.4.362.116","doi-asserted-by":"crossref","first-page":"22821","DOI":"10.1038\/s41598-021-02066-9","article-title":"High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease","volume":"11","author":"Tyker","year":"2021","journal-title":"Sci Rep"},{"key":"2026040105300592000_53.4.362.117","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/art.40900","article-title":"Malondialdehyde-acetaldehyde adducts and antibody responses in rheumatoid arthritis-associated interstitial lung disease","volume":"71","author":"England","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"2026040105300592000_53.4.362.118","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1053\/j.gastro.2022.06.071","article-title":"Malondialdehyde-acetaldehyde extracellular matrix protein adducts attenuate unfolded protein response during alcohol and smoking-induced pancreatitis","volume":"163","author":"Bhatia","year":"2022","journal-title":"Gastroenterology"},{"key":"2026040105300592000_53.4.362.119","doi-asserted-by":"publisher","DOI":"10.1038\/nrg3246"},{"key":"2026040105300592000_53.4.362.120","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220022"},{"key":"2026040105300592000_53.4.362.121","doi-asserted-by":"crossref","first-page":"SI37","DOI":"10.1093\/rheumatology\/keae572","article-title":"Unique transcriptomic profile of peripheral blood monocytes in rheumatoid arthritis-associated interstitial lung disease","volume":"64","author":"Poole","year":"2025","journal-title":"Rheumatology"},{"key":"2026040105300592000_53.4.362.122","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/MCP.0000000000000399","article-title":"Microbiome in interstitial lung disease: from pathogenesis to treatment target","volume":"23","author":"Salisbury","year":"2017","journal-title":"Curr Opin Pulm Med"},{"key":"2026040105300592000_53.4.362.123","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2023-001817"},{"key":"2026040105300592000_53.4.362.124","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s00296-025-05789-4","article-title":"The global prevalence of interstitial lung disease in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"45","author":"Prasanna","year":"2025","journal-title":"Rheumatol Int"},{"key":"2026040105300592000_53.4.362.125","doi-asserted-by":"crossref","first-page":"e851","DOI":"10.1016\/S2665-9913(25)00158-4","article-title":"Risk factors for interstitial lung disease in early rheumatoid arthritis and external validation of screening strategies: a cross-sectional analysis of the prospective SAIL-RA cohort in the USA","volume":"7","author":"McDermott","year":"2025","journal-title":"Lancet Rheumatol"},{"key":"2026040105300592000_53.4.362.126","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.reuma.2022.02.009","article-title":"SER-SEPAR recommendations for the management of rheumatoid arthritis-related interstitial lung disease. Part 1: Epidemiology, risk factors and prognosis","volume":"18","author":"Rodr\u00edguez Portal","year":"2022","journal-title":"Reumatol Clin"},{"key":"2026040105300592000_53.4.362.127","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1007\/s00296-023-05313-6","article-title":"Four-factor risk score for the prediction of interstitial lung disease in rheumatoid arthritis","volume":"43","author":"Koduri","year":"2023","journal-title":"Rheumatol Int"},{"key":"2026040105300592000_53.4.362.128","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41927-024-00389-4","article-title":"Design of ANCHOR-RA: a multi-national cross-sectional study on screening for interstitial lung disease in patients with rheumatoid arthritis","volume":"8","author":"Sparks","year":"2024","journal-title":"BMC Rheumatol"},{"key":"2026040105300592000_53.4.362.129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.rmed.2019.07.006","article-title":"Magnetic resonance imaging of interstitial lung diseases: a state-of-the-art review","volume":"155","author":"Lonzetti","year":"2019","journal-title":"Respir Med"},{"key":"2026040105300592000_53.4.362.130","doi-asserted-by":"crossref","first-page":"102598","DOI":"10.1016\/j.eclinm.2024.102598","article-title":"FAPi PET\/CT for assessment and visualisation of active myositis-related interstitial lung disease: a prospective observational pilot study","volume":"72","author":"Kastrati","year":"2024","journal-title":"EClinicalmedicine"},{"key":"2026040105300592000_53.4.362.131","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1402584"},{"key":"2026040105300592000_53.4.362.132","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60405-4"},{"key":"2026040105300592000_53.4.362.133","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-023-06623-7"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0797","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T12:31:11Z","timestamp":1775046671000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0797"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,1]]},"references-count":133,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4,1]]},"published-print":{"date-parts":[[2026,4]]}},"alternative-id":["10.3899\/jrheum.2025-0797"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0797","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,1]]}}}